
|Articles|November 1, 2003
Eyetech plans IPO of shares of common stock
New York-Eyetech Pharmaceuticals plans to extend an initial public offering of shares of its common stock.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaucoma 2026: Which emerging technologies will change practice?
2
How AI is reshaping ophthalmology in 2025 and beyond
3
Molecular insights and clinical experience: Extending anti-VEGF durability
4
8 things to know about aflibercept 8 mg for retinal vascular disease
5












































